One-, 5-year, and median survival differed significantly between chondrosarcomas subtypes. The highest median survival was found in the juxtacortical subtype (97 months), followed by clear cell (79 months), myxoid (60 months), mesenchymal (33.5 months), and lowest in dedifferentiated (11 months).

Survival rate for a young sarcoma patient can be varied anywhere from 5-10 years depending on the age of the patient and site of tumor. A 5 year survival rate for a child younger than 15 years is believed to be 76% and that of a 15-19 years aged child is 59%. Patients with localized tumours have 81% of 5 year survival rate and those with a diffused or metastatic tumours has 15% of 5 year survival rate.

If the cancer has spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year relative survival rate is 85%. If the cancer has spread to distant parts of the body, the 5-year relative survival rate is 61%. There are multiple types of chondrosarcoma.

Chondrosarcoma affects men and women equally, and typically appears in people between ages 40 and 75. The average age at diagnosis is 51. Is chondrosarcoma a common form of cancer? No, it’s not common. Approximately 600 people are diagnosed with chondrosarcoma each year. Are there different types of chondrosarcoma?